Fibroblasts from IPF patients are known to overexpress CTGF [57]: future studies will elucidate whether this growth factor may influence the occurrence of cardiovascular comorbidities during the natural history of IPF. The gene discussed is CCN2; the disease is idiopathic pulmonary fibrosis.